An assessment of 265 biopharmaceutical facilities in the 35 countries comprising the Europe, the Middle East and Africa (EMEA) region found that the combined production of the sites in 2014 was more than 2.4 million L. Among the sites, 26%, 18%, 15% manufactured recombinant proteins only, vaccines only, or “other” (excluding mAbs and blood processing), […]

This month, US President Obama and the EPA unveiled the Clean Power Plan, which regulates emissions from new, modified and reconstructed power plants. The Plan, when fully implemented, calls for carbon, sulfur dioxide and nitrogen oxides emissions from power plants to be reduced nationally to 32%, 90% and 72% below 2005 levels, respectively. States must […]